Ocumension Therapeutics
HKEX:1477.HK
5.43 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 842.839 | 1,170.049 | 1,125.221 | 2,034.319 | 192.404 | 25.629 |
| Short Term Investments
| 206.662 | 118.398 | 640 | 0 | 1,055.749 | 66.268 |
| Cash and Short Term Investments
| 1,049.501 | 1,288.447 | 1,765.221 | 2,034.319 | 1,248.153 | 91.897 |
| Net Receivables
| 97.747 | 138.711 | 18.509 | 7.81 | 0.096 | 0 |
| Inventory
| 32.473 | 24.104 | 4.993 | 3.027 | 0.259 | 0 |
| Other Current Assets
| 21.613 | 3.898 | 25.844 | 40.748 | 511.138 | 1.099 |
| Total Current Assets
| 1,205.634 | 1,455.16 | 1,834.567 | 2,103.404 | 1,261.993 | 92.996 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 467.651 | 448.069 | 365.862 | 82.025 | 2.015 | 1.386 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 1,140.181 | 919.05 | 709.973 | 201.652 | 25 | 0 |
| Goodwill and Intangible Assets
| 1,140.181 | 919.05 | 709.973 | 201.652 | 25 | 0 |
| Long Term Investments
| 364.148 | -23.398 | -367.599 | 0 | 0 | 0 |
| Tax Assets
| 0 | 23.398 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 93.385 | 221.395 | 788.25 | 212.481 | 0.689 | 0.24 |
| Total Non-Current Assets
| 2,065.365 | 1,588.514 | 1,496.486 | 496.158 | 27.704 | 1.626 |
| Total Assets
| 3,270.999 | 3,043.674 | 3,331.053 | 2,599.562 | 1,289.697 | 94.622 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 25.192 | 21.703 | 4.407 | 9.343 | 3.94 | 0.013 |
| Short Term Debt
| 132.326 | 12.285 | 4.186 | 1.927 | 1.259 | 0.602 |
| Tax Payables
| 2.271 | 1.546 | 2.399 | 1.439 | 0.2 | 0.05 |
| Deferred Revenue
| -12.326 | 0 | 0 | 0 | 0 | -0.602 |
| Other Current Liabilities
| 170.092 | 213.665 | 207.261 | 80.655 | 34.236 | 4.041 |
| Total Current Liabilities
| 315.284 | 247.653 | 215.854 | 91.925 | 39.435 | 4.054 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 5.657 | 17.292 | 7.026 | 5.309 | 3,318.75 | 0.524 |
| Deferred Revenue Non-Current
| 30.09 | 30.09 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| -30.09 | -30.09 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 30.09 | 30.09 | 0 | 0 | -3,318.75 | 867.348 |
| Total Non-Current Liabilities
| 35.747 | 47.382 | 7.026 | 5.309 | 3,318.75 | 867.872 |
| Total Liabilities
| 351.031 | 295.035 | 222.88 | 97.234 | 3,358.185 | 871.926 |
| Equity: | ||||||
| Preferred Stock
| 0 | 232.436 | 202.793 | 258.685 | 550.664 | 822.247 |
| Common Stock
| 0.048 | 0.048 | 0.046 | 0.041 | 0.004 | 0.002 |
| Retained Earnings
| -4,721.578 | -4,446.714 | -4,044.549 | -3,784.56 | -1,519.919 | -207.608 |
| Accumulated Other Comprehensive Income/Loss
| 2,919.92 | -232.436 | -202.793 | -258.685 | -550.664 | -614.639 |
| Other Total Stockholders Equity
| 4,721.578 | 7,195.305 | 7,152.676 | 6,286.847 | -548.573 | -821.098 |
| Total Shareholders Equity
| 2,919.968 | 2,748.639 | 3,108.173 | 2,502.328 | -2,068.488 | -821.096 |
| Total Equity
| 2,919.968 | 2,748.639 | 3,108.173 | 2,502.328 | -2,068.488 | -777.304 |
| Total Liabilities & Shareholders Equity
| 3,270.999 | 3,043.674 | 3,331.053 | 2,599.562 | 1,289.697 | 94.622 |